Answers are grounded in this paper and cite their sources.
It already exists within the US Food and Drug Administration, argues a former clinical reviewer of psychotropic drugs at the FDA
No takes yet. Share an insight, caveat, or question.
Erick H. Turner (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: